News

PMGC Stock Surges After Subsidiary Inks Deal With Yuva Biosciences To Develop AI Led Therapies
PMGC Holdings is gaining in premarket trading after its subsidiary, Northstrive Biosciences, partnered with Yuva Biosciences ...
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial ...
PMGC’s Northstrive Biosciences signs partnership with Yuva Biosciences
Northstrive Biosciences, a subsidiary of PMGC Holdings, announced today that it has entered into a Development and License Agreement with Yuva Biosciences to discover and develop ...
BioWorld8d
Northstrive partners with Yuva Biosciences on obesity and cardiometabolic diseases
Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc., has entered into a development and license agreement with Yuva Biosciences Inc. to discover and develop novel pharmaceutical ...
Investing8d
Northstrive, Yuva Biosciences partner on cardiometabolic treatments
NEWPORT BEACH, Calif. - Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB), a micro-cap biotech company currently valued at $2.82 million, has announced a partnership with ...
Morningstar9d
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and ...
manilatimes9d
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
Northstrive Biosciences and Yuva Biosciences' collaboration will leverage MitoNova™, YuvaBio's proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel ...